Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 2:59 pm Purchase | 2022-12-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Wellington Management Group LLP | 3,618,493 6.340% | 3,618,493 (New Position) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | BlackRock Inc. BLK | 3,472,179 6.100% | 629,234 (+22.13%) | Filing History |
| 2022-06-03 10:52 am Purchase | 2022-05-18 | 13D | Zentalis Pharmaceuticals, Inc. ZNTL | Matrix Capital Management Company, LP | 9,199,973 16.450% | 4,850,694 (+111.53%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Redmile Group, LLC | 0 0.000% | -2,416,406 (Position Closed) | Filing History |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | VIKING GLOBAL INVESTORS LP | 2,118,284 4.700% | -893,000 (-29.66%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | T. Rowe Price Associates, Inc. | 4,382,881 9.600% | 4,382,881 (New Position) | Filing History |
| 2022-02-14 12:06 pm Sale | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 5.800% | -36,000 (-1.35%) | Filing History |
| 2022-02-14 12:03 pm Purchase | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Matrix Capital Management Company, LP | 4,349,279 9.600% | 527,540 (+13.80%) | Filing History |
| 2022-02-10 5:07 pm Purchase | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Zentalis Pharmaceuticals Inc. ZNTL | 2,859,377 6.200% | 2,859,377 (New Position) | Filing History |
| 2022-02-10 08:47 am Purchase | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | The Vanguard Group | 3,186,986 7.030% | 840,849 (+35.84%) | Filing History |
| 2022-02-09 10:04 am Purchase | 2022-02-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | FMR LLC | 6,795,831 14.999% | 703,753 (+11.55%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | BlackRock Inc. BLK | 2,842,945 6.300% | 567,796 (+24.96%) | Filing History |
| 2022-02-01 3:33 pm Purchase | 2022-01-25 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Avidity Partners Management LP | 3,022,790 6.700% | 3,022,790 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Citadel Advisors LLC | 1,503,870 3.700% | -626,094 (-29.39%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Redmile Group, LLC | 2,416,406 6.000% | 2,416,406 (New Position) | Filing History |
| 2021-02-16 10:02 am Purchase | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Matrix Capital Management Company, LP | 3,821,739 9.410% | 3,821,739 (New Position) | Filing History |
| 2021-02-12 7:52 pm Sale | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | VIKING GLOBAL INVESTORS LP | 3,011,284 7.400% | -1,432,000 (-32.23%) | Filing History |
| 2021-02-10 12:04 pm Purchase | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | The Vanguard Group | 2,346,137 5.780% | 2,346,137 (New Position) | Filing History |
| 2021-02-08 10:35 am Purchase | 2021-02-05 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | FMR LLC | 6,092,078 14.999% | 1,085,906 (+21.69%) | Filing History |
| 2021-02-03 5:27 pm Purchase | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | SUN ANTHONY Y | 2,991,907 7.300% | 2,991,907 (New Position) | Filing History |